Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis

Version 1 : Received: 12 September 2020 / Approved: 13 September 2020 / Online: 13 September 2020 (23:45:55 CEST)

A peer-reviewed article of this Preprint also exists.

Schilke, R.M.; Blackburn, C.M.R.; Bamgbose, T.T.; Woolard, M.D. Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis. Biomolecules 2020, 10, 1449. Schilke, R.M.; Blackburn, C.M.R.; Bamgbose, T.T.; Woolard, M.D. Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis. Biomolecules 2020, 10, 1449.

Journal reference: Biomolecules 2020, 10, 1449
DOI: 10.3390/biom10101449

Abstract

Phospholipases are a family of lipid altering enzymes that can either reduce or increase bioactive lipid levels. Bioactive lipids elicit signaling responses, activate transcription factors, promote g-coupled protein activity, and modulate membrane fluidity that mediate cellular function. Phospholipases and the bioactive lipids they produce are important regulators on immune cell activity, dictating both pro-inflammatory and pro-resolving activity. During atherosclerosis, pro-inflammatory and pro-resolving activities govern atherosclerosis progression and regression respectively. This review will look at the interface of phospholipase activity, immune cell function, and atherosclerosis.

Subject Areas

Atherosclerosis; Phospholipases; Macrophages; T cells; Lipins

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.